Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| Genmab, articles of association on December 13, 2006 | 3 Jan 2007 |
| Genmab, Financial Calendar for 2007 | 2 Jan 2007 |
| Genmab, GlaxoSmithKline and Genmab Enter Global Agreement for HuMax-CD20 | 19 Dec 2006 |
| Genmab, Announcement of Additional Details Concerning the Issue of Shares to GlaxoSmithKline | 19 Dec 2006 |
| InvestorService: Genmab, Announces AMG 714 Development Update | 15 Dec 2006 |